High maternal serum estradiol levels induce dyslipidemia in human newborns via a hepatic HMGCR estrogen response element

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Meng, Ye ^b   Lv, Ping Ping ^b   Ding, Guo Lian ^a,d   Yu, Tian Tian ^a,b   Liu, Ye ^a,d   Shen, Yan ^b   Hu, Xiao Ling ^b   Lin, Xian Hua ^a,b,d   Tian, Shen ^b   Lv, Min ^b   Song, Yang ^b   Guo, Meng Xi ^b   Ke, Zhang Hong ^b   Xu, Hong ^a,d   Sheng, Jian Zhong ^b,c   Shi, Feng Tao ^a,d   Huang, He Feng ^a,b,d  

^a School of Medicine   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c ZHEJIANG UNIVERSITY   (China)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; HMGCR PROTEIN, HUMAN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL; BLOOD; DISEASE MODEL; DYSLIPIDEMIAS; FEMALE; HEP-G2 CELL LINE; HUMAN; INFANT, NEWBORN, DISEASES; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; METABOLISM; MOUSE; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION;

ANIMALS; CHOLESTEROL, LDL; DISEASE MODELS, ANIMAL; DYSLIPIDEMIAS; ESTRADIOL; FEMALE; HEP G2 CELLS; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MALE; MICE; MICE, INBRED ICR; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84929223498     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10086     Document Type: Article

References (40)

1. Bateson, P. et al. Developmental plasticity and human health. Nature 430, 419-421 (2004).
2. Gluckman, P. D., Hanson, M. A., Cooper, C. & Thornburg, K. L. Effect of in utero and early-life conditions on adult health and disease. N. Engl. J. Med. 359, 61-73 (2008).
3. Singhal, A. & Lucas, A. Early origins of cardiovascular disease: is there a unifying hypothesis? Lancet 363, 1642-1645 (2004).
4. Dong, M. Y., Wang, F. F., Pan, J. X. & Huang, H. F. [Adverse intrauterine environment and gamete/embryo-fetal origins of diseases] Gamete and Embryo-fetal Origins of Adult Diseases [Huang, H. F., Sheng, J. Z. (ed.)] [61-78] (Springer, Netherlands, 2014).
5. Gluckman, P. D., Hanson, M. A. & Beedle, A. S. Early life events and their consequences for later disease: a life history and evolutionary perspective. Am. J. Hum. Biol. 19, 1-19 (2007).
6. Nicoletto, S. F. & Rinaldi, A. In the womb's shadow. The theory of prenatal programming as the fetal origin of various adult diseases is increasingly supported by a wealth of evidence. EMBO. Rep. 12, 30-34 (2011).
7. Pakkila, F. et al. The impact of gestational thyroid hormone concentrations on ADHD symptoms of the child. J. Clin. Endocrinol. Metab. 99, E1-8 (2014).
8. Bauer, S. M. et al. The effects of maternal exposure to bisphenol A on allergic lung inflammation into adulthood. Toxicol. Sci. 130, 82-93 (2012).
9. Borrow, A. P., Levy, M. J., Soehngen, E. P. & Cameron, N. M. Perinatal testosterone exposure and maternal care effects on the female rat's development and sexual behaviour. J. Neuroendocrinol. 25, 528-536 (2013).
10. Ferraretti, A. P. et al. Assisted reproductive technology in Europe, 2009: results generated from European registers by ESHRE. Hum. Reprod. 28, 2318-2331 (2013).
11. Imudia, A. N. et al. Peak serum estradiol level during controlled ovarian hyperstimulation is associated with increased risk of small for gestational age and preeclampsia in singleton pregnancies after in vitro fertilization. Fertil. Steril. 97, 1374-1379 (2012).
12. Hu, X. L. et al. High maternal serum estradiol environment in the first trimester is associated with the increased risk of smallfor- gestational-age birth. J. Clin. Endocrinol. Metab. 99, 2217-2224 (2014).
13. Ruiz, J. R. et al. Birth weight and blood lipid levels in Spanish adolescents: influence of selected APOE, APOC3 and PPARgamma2 gene polymorphisms. The AVENA Study. BMC. Med. Genet. 9, 98 (2008).
14. Jaquet, D., Leger, J., Levy-Marchal, C. & Czernichow, P. Low birth weight: effect on insulin sensitivity and lipid metabolism. Horm. Res. 59, 1-6 (2003).
15. Whincup, P.H. et al. Birth weight and risk of type 2 diabetes: a systematic review. JAMA 300, 2886-2897 (2008).
16. Huxley, R., Neil, A. & Collins, R. Unravelling the fetal origins hypothesis: is there really an inverse association between birthweight and subsequent blood pressure? Lancet 360, 659-665 (2002).
17. Martinez-Mesa, J. et al. Life-course evidence of birth weight effects on bone mass: systematic review and meta-analysis. Osteoporos. Int. 24, 7-18 (2013).
18. Grodstein, F. et al. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann. Intern. Med. 133, 933-941 (2000).
19. Wakeling, A. E., Dukes, M. & Bowler, J. A potent specific pure antiestrogen with clinical potential. Cancer. Res. 51, 3867-3873 (1991).
20. Pilling, J., Garside, H. & Ainscow, E. Development of a quantitative 96-well method to image glycogen storage in primary rat hepatocytes. Mol. Cell. Biochem. 341, 73-78 (2010).
21. Klein-Hitpass, L., Schorpp, M., Wagner, U. & Ryffel, G. U. An estrogen-responsive element derived from the 5' flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell 46, 1053-1061 (1986).
22. Chen, M., Norman, R. J. & Heilbronn, L. K. Does in vitro fertilisation increase type 2 diabetes and cardiovascular risk? Curr. Diabetes. Rev. 7, 426-432 (2011).
23. Gude, N. M., Roberts, C. T., Kalionis, B. & King, R. G. Growth and function of the normal human placenta. Thromb. Res. 114, 397-407 (2004).
24. Gracia, C. R. et al. Thyroid function during controlled ovarian hyperstimulation as part of in vitro fertilization. Fertil. Steril. 97, 585-591 (2012).
25. Seggers, J. et al. Is ovarian hyperstimulation associated with higher blood pressure in 4-year-old IVF offspring? Part I: multivariable regression analysis. Hum. Reprod. 29, 502-509 (2014).
26. Bertolini, M., Wallace, C. R. & Anderson, G. B. Expression profile and protein levels of placental products as indirect measures of placental function in in vitro-derived bovine pregnancies. Reproduction. 131, 163-73 (2006).
27. Zhang, Y. et al. Comparative proteomic analysis of human placenta derived from assisted reproductive technology. Proteomics. 8, 4344-56 (2008).
28. Jiang, J., Nilsson-Ehle, P. & Xu, N. Influence of liver cancer on lipid and lipoprotein metabolism. Lipids. Health. Dis. 5, 4 (2006).
29. Fawell, S. E. et al. Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164, 384 appears to be mediated by impaired receptor dimerization. Proc. Natl. Acad. Sci. USA 87, 6883-6887 (1990).
30. Dauvois, S., White, R. & Parker, M. G. The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J. Cell. Sci. 106, 1377-1388 (1993).
31. Dauvois, S., Danielian, P. S., White, R. & Parker, M. G. Antiestrogen ICI 164, 384 reduces cellular estrogen receptor content by increasing its turnover. Proc. Natl. Acad. Sci. USA 89, 4037-4041 (1992).
32. Brizzi, P. et al. Effect of ovarian stimulation on plasma lipid and apolipoprotein concentrations in a population of infertile women undergoing IVF/embryo transfer. Reprod. Biomed. Online. 7, 309-12 (2003).
33. Yagyu, H. et al. Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy. J. Clin. Invest. 111, 419-426 (2003).
34. Hovingh, G. K. et al. Compromised LCAT function is associated with increased atherosclerosis. Circulation 112, 879-884 (2005).
35. Ikonen, E. Mechanisms for cellular cholesterol transport: defects and human disease. Physiol. Rev. 86, 1237-1261 (2006).
36. Fox, K. M., Gandhi, S. K., Ohsfeldt, R. L. & Davidson, M. H. Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting. Am. J. Manag. Care. (Suppl 10), S270-275 (2007).
37. Klinge, C. M. Estrogen receptor interaction with estrogen response elements. Nucleic. Acids. Res. 29, 2905-2919 (2001).
38. Gruber, C. J., Gruber, D. M., Gruber, I. M., Wieser, F. & Huber, J. C. Anatomy of the estrogen response element. Trends. Endocrinol. Metab. 15, 73-78 (2004).
39. Kondapalli, L. A., Molinaro, T. A., Sammel, M. D. & Dokras, A. A decrease in serum estradiol levels after human chorionic gonadotrophin administration predicts significantly lower clinical pregnancy and live birth rates in in vitro fertilization cycles. Hum. Reprod. 27, 2690-2697 (2012).
40. Naito, M., Takahashi, K. & Nishikawa, S. Development, differentiation, and maturation of macrophages in the fetal mouse liver. J. Leukoc. Biol. 48, 27-37 (1990).